BioMarin Pharmaceutical (BMRN) Proxy filing summary

Voting matters and shareholder proposals

• Election of ten directors, with all nominees recommended for approval by the board.

• Ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

• Advisory approval of executive compensation for Named Executive Officers.

• Approval of an amendment to the 2017 Equity Incentive Plan.

• Proxy holders authorized to vote on other business or substitute nominees if necessary.

Board of directors and corporate governance

• Ten director nominees are presented for election at the annual meeting.

• Board recommends voting in favor of all director nominees.

Executive compensation and say-on-pay

• Advisory vote on the compensation of Named Executive Officers is included as a proposal.

• Amendment to the 2017 Equity Incentive Plan is up for shareholder approval.